Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Aucta Pharmaceuticals

02 2Towa International

03 1Acme Lifetech

04 1Aeron Remedies

05 2Alter Laboratories Sa

06 2Alventa Pharma

07 4Amneal Pharmaceuticals

08 4Aurobindo Pharma Limited

09 2Caristar Laboratories

10 1Carnegie Pharmaceuticals

11 2Cinfa

12 2Delius Pharmaceuticals

13 2Dycine Pharma

14 2Efarmes Sau

15 8Faes Farma

16 1Halewood Laboratories Pvt. Ltd

17 1Hanlim Pharmaceuticals Inc

18 2Kern Pharma S.L.

19 3LAB.GUIDOTTI SpA

20 2LABORATORIOS NORMON SA

21 3Menarini

22 1Myungmoon Pharm. Co., LTD.

23 5PTC Therapeutics

24 2STADA Arzneimittel

25 2Sandoz B2B

26 7Sun Pharmaceutical Industries Limited

27 2Swasthya Healthcare

28 3TEOFARMA Srl

29 1Tarbis Farma Sl

30 1Themis Medicare

31 1Tris Pharma Inc

32 1Unicor Pharmatech

33 5Upsher-Smith Laboratories

34 1Vaishali Pharma Ltd

35 1Vega Biotech Pvt. Ltd.

36 2Vir Sa Chemical And Pharmaceutical Industry

37 1XGX Pharma ApS

38 2Xgx Pharma Aps

39 5ZRS LABS

40 1Zota Healthcare Ltd

41 5Zydus Lifesciences

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAucta is a global brand that creates better products from proven molecules.

Regulatory Info : RX

Registration Country : USA

DEFLAZACORT

Brand Name : PYQUVI

Dosage Form : SUSPENSION;ORAL

Dosage Strength : 22.75MG/ML

Packaging :

Approval Date : 2025-06-30

Application Number : 219417

Regulatory Info : RX

Registration Country : USA

Aucta Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa International works to research, develop, manufacture, and market, generic and value-added medicines to patients around the world.

Regulatory Info : Authorized

Registration Country : Spain

Deflazacort

Brand Name : Deflazacort Pensa

Dosage Form : Tablet

Dosage Strength : 30MG

Packaging :

Approval Date : 13-04-2011

Application Number : 73882

Regulatory Info : Authorized

Registration Country : Spain

Towa Pharmaceutical

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa International works to research, develop, manufacture, and market, generic and value-added medicines to patients around the world.

Regulatory Info : Suspended

Registration Country : Spain

Deflazacort

Brand Name : Deflazacort Pensa

Dosage Form : Tablet

Dosage Strength : 6MG

Packaging :

Approval Date : 13-04-2011

Application Number : 73883

Regulatory Info : Suspended

Registration Country : Spain

Towa Pharmaceutical

04

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2025-12-12

Application Number : 217173

Regulatory Info : RX

Registration Country : USA

blank

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2025-12-12

Application Number : 217173

Regulatory Info : RX

Registration Country : USA

blank

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2025-12-12

Application Number : 217173

Regulatory Info : RX

Registration Country : USA

blank

07

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2024-02-09

Application Number : 217123

Regulatory Info : RX

Registration Country : USA

blank

08

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2024-02-09

Application Number : 217123

Regulatory Info : RX

Registration Country : USA

blank

09

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2024-02-09

Application Number : 217123

Regulatory Info : RX

Registration Country : USA

blank

10

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 36MG

Packaging :

Approval Date : 2024-02-09

Application Number : 217123

Regulatory Info : RX

Registration Country : USA

blank

11

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2017-02-09

Application Number : 208684

Regulatory Info : RX

Registration Country : USA

blank

12

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2017-02-09

Application Number : 208684

Regulatory Info : RX

Registration Country : USA

blank

13

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2017-02-09

Application Number : 208684

Regulatory Info : RX

Registration Country : USA

blank

14

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : TABLET;ORAL

Dosage Strength : 36MG

Packaging :

Approval Date : 2017-02-09

Application Number : 208684

Regulatory Info : RX

Registration Country : USA

blank

15

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : SUSPENSION;ORAL

Dosage Strength : 22.75MG/ML

Packaging :

Approval Date : 2017-02-09

Application Number : 208685

Regulatory Info : RX

Registration Country : USA

blank

16

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2024-11-05

Application Number : 216720

Regulatory Info : RX

Registration Country : USA

blank

17

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2024-11-05

Application Number : 216720

Regulatory Info : RX

Registration Country : USA

blank

18

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2024-11-05

Application Number : 216720

Regulatory Info : RX

Registration Country : USA

blank

19

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 36MG

Packaging :

Approval Date : 2024-11-05

Application Number : 216720

Regulatory Info : RX

Registration Country : USA

blank

20

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : SUSPENSION;ORAL

Dosage Strength : 22.75MG/ML

Packaging :

Approval Date : 2025-08-11

Application Number : 216992

Regulatory Info : RX

Registration Country : USA

blank